by PEAK Medicals | 18 December 2024
BREAST CANCER REVIEW 2024 Latest treatment updates in Early Breast Cancer Peter Dubsky Highlighted data of 2024 in HER2+ / HR+ Adv. Breast Cancer Nadia Harbeck Practice-changing studies of 2024 in advanced TNBC Khalil Zaman  } 1 h 32 min Get Your CME...
by PEAK Medicals | 17 December 2024
LUNG CANCER 2024 REVIEW Druggable since 2024: an overview of newly approved therapies for NSCLC Solange Peters Highlights of the year in targeted therapies Jordi Remon Highlights of the year in immunotherapies Hossein Borghaei  } 1 h 43 min Get Your CME...
by PEAK Medicals | 15 November 2024
DISKUSSIONSFORUM FÜR URO-ONKOLOGIE Neue Standards im Urothelkarzinom und das Management ihrer Nebenwirkungen Maria De Santis Prostatakarzinom: Wie lassen sich die neuen Therapien für mHSPC und mCRPC integrieren? Shahrokh F. Shariat Neue Behandlungsmöglichkeiten beim...
by PEAK Medicals | 6 November 2024
Antibody Drug Conjugates WELCOME & INTRODUCTION BY HOST Alessandra Curioni EMERGING TRENDS & CLINICAL IMPACT OF ADCs IN GENITOURINARY CANCERS Giuseppe Banna CURRENT AND FUTURE STANDARDS OF ADCs IN BREAST CANCER CARE Paolo Tarantino NEW DEVELOPMENTS IN LUNG CANCER CARE...
by PEAK Medicals | 2 July 2024
Breast Cancer (ASCO 2024) Welcome & introduction by host Jens Huober Latest treatment updates in early breast cancer Konstantin Dedes How does the latest ASCO data integrate into the treatment of TNBC and HER2+ advanced breast cancer? Isabell Witzel Where do we stand...
